Alphina Therapeutics
Biotechnology Research
New Haven, Ct, United States
10 employees
- Employees
- 10
- Contacts
- 3
- Emails
- 3
- Phones
- 2
Alphina Therapeutics Overview
- Headquarters
- New Haven, Ct, United States
- Website
- www.alphinatx.com
- Industry
- Biotechnology Research
- Employees
- 10
- Founded
- 2020
- Funding
- 16.9M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Alphina Therapeutics
Alphina Therapeutics is a biotechnology company focused on precision medicine in cancer
Alphina Therapeutics Contact Details
- People in AeroLeads
- 3
- With contact data
- 3
- Email contacts
- 3
- 100.0% coverage
- Phone contacts
- 2
- 66.7% coverage
Alphina Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Daniel Wagner | Early Stage Life Science Investor | Hamden, Connecticut, United States |
Email
Phone
|
| Nick Galli | CEO at Alphina Therapeutics | New Haven, Connecticut, United States |
Email
Phone
|
| Marc Damelin | Chief Scientific Officer at Alphina | Cambridge, Massachusetts, United States |
Email
|
Employees by Management Level
Executive
2 profiles
Individual contributor
1 profile
Compare Similar Companies to Alphina Therapeutics
Biohaven
Biotechnology Research
Arvinas
Biotechnology Research
Kymera Therapeutics
Biotechnology Research
EvolveImmune Therapeutics
Biotechnology Research
Halda Therapeutics
Biotechnology Research
Trevi Therapeutics, Inc.
Biotechnology Research
Rallybio
Biotechnology Research
BioCT
Biotechnology Research
Cybrexa Therapeutics
Biotechnology Research
Modifi Bio
Biotechnology